|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003280,
umls-concept:C0007784,
umls-concept:C0016709,
umls-concept:C0018270,
umls-concept:C0018944,
umls-concept:C0030705,
umls-concept:C0042878,
umls-concept:C0072434,
umls-concept:C0087111,
umls-concept:C0439849,
umls-concept:C0442027,
umls-concept:C0445223,
umls-concept:C0520010,
umls-concept:C0679199,
umls-concept:C1274040,
umls-concept:C1522326,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1707455,
umls-concept:C1947933
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-5-29
|
|
pubmed:abstractText |
Intracerebral hemorrhage (ICH) is the most serious and potentially fatal complication of oral anticoagulant therapy (OAT). Still, there are no universally accepted treatment regimens for patients with OAT-ICH, and randomized controlled trials do not exist. The aim of the present study was to compare the acute treatment strategies of OAT-associated ICH using vitamin K (VAK), fresh frozen plasma (FFP), and prothrombin complex concentrates (PCCs) with regard to hematoma growth and outcome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1524-4628
|
|
pubmed:author |
pubmed-author:HartmannMariusM,
pubmed-author:HuttnerHagen BHB,
pubmed-author:JuettlerEricE,
pubmed-author:KöhrmannMartinM,
pubmed-author:MansmannUlrichU,
pubmed-author:Meyding-LamadeUtaU,
pubmed-author:MuellerStephanS,
pubmed-author:SchellingerPeter DPD,
pubmed-author:SchwabStefanS,
pubmed-author:SteinerThorstenT,
pubmed-author:StroblRalfR,
pubmed-author:WiknerJohannesJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1465-70
|
|
pubmed:meshHeading |
pubmed-meshheading:16675739-Administration, Oral,
pubmed-meshheading:16675739-Aged,
pubmed-meshheading:16675739-Anticoagulants,
pubmed-meshheading:16675739-Blood Coagulation Factors,
pubmed-meshheading:16675739-Blood Component Transfusion,
pubmed-meshheading:16675739-Cerebral Hemorrhage,
pubmed-meshheading:16675739-Critical Care,
pubmed-meshheading:16675739-Female,
pubmed-meshheading:16675739-Hematoma,
pubmed-meshheading:16675739-Humans,
pubmed-meshheading:16675739-Magnetic Resonance Imaging,
pubmed-meshheading:16675739-Male,
pubmed-meshheading:16675739-Middle Aged,
pubmed-meshheading:16675739-Plasma,
pubmed-meshheading:16675739-Retrospective Studies,
pubmed-meshheading:16675739-Tomography, X-Ray Computed,
pubmed-meshheading:16675739-Treatment Outcome,
pubmed-meshheading:16675739-Vitamin K
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates.
|
|
pubmed:affiliation |
Department of Neurology, University of Heidelberg, Germany. hagen.huttner@neuro.imed.uni-erlangen.de
|
|
pubmed:publicationType |
Journal Article
|
